NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 829 filers reported holding NOVARTIS A G in Q1 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $10,748,000 | -48.0% | 116,930 | -44.4% | 0.01% | -40.0% |
| Q2 2015 | $20,676,000 | -0.3% | 210,250 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $20,733,000 | +6.4% | 210,250 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $19,482,000 | -1.6% | 210,250 | 0.0% | 0.01% | -9.1% |
| Q3 2014 | $19,791,000 | -48.0% | 210,250 | -50.0% | 0.01% | +10.0% |
| Q2 2014 | $38,068,000 | +113.0% | 420,500 | +100.0% | 0.01% | 0.0% |
| Q1 2014 | $17,875,000 | +5.8% | 210,250 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $16,900,000 | +4.8% | 210,250 | 0.0% | 0.01% | +11.1% |
| Q3 2013 | $16,128,000 | +8.5% | 210,250 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $14,867,000 | -0.7% | 210,250 | 0.0% | 0.01% | -10.0% |
| Q1 2013 | $14,978,000 | +16.3% | 210,250 | 0.0% | 0.01% | +11.1% |
| Q3 2012 | $12,880,000 | +4.5% | 210,250 | 0.0% | 0.01% | -10.0% |
| Q2 2012 | $12,325,000 | – | 210,250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |